You’re taking Wegovy because it works — the weight is coming off, your health markers are improving, and you’re feeling better about the direction things are heading. But then you notice the shedding. More hair on your brush, in the shower, on your clothes. Wegovy hair loss is real, it’s common, and if you’re a woman, you’re at higher risk than the clinical trials suggest.
The good news: for most women, this shedding is temporary. The important caveat: “most” isn’t “all” — and Wegovy’s higher potential semaglutide dose means it can trigger more significant hair loss than other GLP-1 medications. Understanding why, and knowing when temporary shedding might be masking something more, is what separates a wait-and-see approach from one that actually protects your hair.
What Is Wegovy — and Why Does It Cause Hair Loss?
Wegovy is semaglutide at a higher dose than Ozempic — 2.4mg weekly compared to Ozempic’s maximum of 2mg. It’s the only semaglutide product specifically licensed in the UK for weight management, approved by NICE in 2023 for NHS prescribing. This distinction matters: if you’re taking Wegovy, you’re on a weight loss medication by design, not off-label.
In Wegovy’s clinical trials, hair loss was reported in 3% of participants compared to 1% on placebo. A 2025 University of British Columbia study found that women taking semaglutide had more than double the risk of hair loss compared to women on alternative weight loss medication. And real-world experience suggests these figures undercount the problem — particularly among women.
The hair loss has a name: telogen effluvium. It’s not the semaglutide itself damaging your follicles. It’s what the medication does — suppress appetite, drive rapid weight loss, shift your metabolic balance — that pushes hair follicles prematurely into their resting phase. Two to four months later, those resting hairs shed.
But telogen effluvium isn’t always the full story. For a detailed explanation of the four mechanisms connecting GLP-1 medications to hair loss — including nutritional deficiency, hormonal shifts, and metabolic stress — see our comprehensive guide to Ozempic and hair loss.
Why Wegovy May Trigger More Hair Loss Than Other GLP-1s
Not all GLP-1 medications carry the same hair loss risk. Wegovy’s profile is distinct — and understanding why helps explain what you can do about it.
Higher semaglutide dose. Wegovy’s maintenance dose of 2.4mg weekly is 20% higher than Ozempic’s maximum dose. More semaglutide means more appetite suppression, which typically means faster, more significant weight loss — and more dramatic weight loss is a stronger trigger for telogen effluvium.
Greater average weight loss. Wegovy trials showed approximately 15% body weight reduction over 68 weeks. That’s a substantial metabolic shift — enough to trigger the kind of physiological stress response that pushes hair follicles into their resting phase.
More significant appetite suppression. At 2.4mg, appetite suppression is pronounced. Many women find they eat considerably less than before — which is the point of the medication, but it creates a real risk of inadequate protein, iron, and zinc intake even when diet quality is good. Your hair follicles are among the most metabolically demanding cells in your body, and they’re the first to suffer when nutrients run short.
Long-term prescribing. Unlike short-term weight loss interventions, Wegovy is designed for ongoing use. This means the caloric restriction that triggers telogen effluvium can persist for longer than with a typical diet — extending the window during which hair follicles are under nutritional pressure.
Is It Temporary — or Something More?
For most women on Wegovy, the answer is straightforward: it’s telogen effluvium, it’s temporary, and your hair will recover within six to twelve months of your weight stabilising.
But not always.
Rapid weight loss reduces oestrogen levels — fat tissue is metabolically active and produces oestrogen. For women with a genetic predisposition to female pattern hair loss, this hormonal shift can unmask pattern thinning that was previously held in check by higher oestrogen. This type of hair loss is progressive and won’t resolve on its own, regardless of whether you continue or stop Wegovy.
If you’re in your 40s or 50s, perimenopause adds another layer. Declining oestrogen from menopause plus declining oestrogen from fat loss plus reduced nutrient intake — that’s three simultaneous mechanisms working against your hair. A “just wait and see” approach risks losing ground on a progressive condition during the months you spend waiting.
The critical diagnostic step is scalp microscopy (trichoscopy). It can distinguish between healthy follicles temporarily at rest — which is telogen effluvium — and miniaturising follicles, which indicates female pattern hair loss. The treatment for each is completely different, and only a proper assessment can tell you which applies to you. Our Ozempic hair loss guide explains the three diagnostic scenarios in detail.
Concerned about hair thinning on Wegovy? Book a consultation with our specialist team — £300 including examination, trichoscopy, and a personalised treatment plan.
Book a Consultation
If you're experiencing Wegovy hair loss, a proper diagnosis is the first step toward the right treatment.
Our consultation includes a full clinical assessment, dermoscopy, and a personalised treatment plan — all in a single appointment.
Book your consultation today — £300Including assessment, and treatment plan. See full pricing
What You Can Do About Wegovy Hair Loss
Evidence-Based Approaches
Nutritional optimisation is the foundation — and it’s particularly important at Wegovy’s top 2.4mg dose, where appetite suppression can make adequate intake genuinely difficult. Protein should be at least 1.2g per kilogram of body weight daily. Iron stores need to reach a ferritin level above 70 µg/L — not the 12 µg/L your GP may accept as “normal.” Our blood test panel uses hair-specific thresholds to identify exactly which deficiencies need addressing.
Topical minoxidil can accelerate telogen effluvium recovery and is the gold-standard treatment for any underlying female pattern hair loss. Oral minoxidil is an option if topical isn’t tolerated — this requires doctor supervision and isn’t available from most trichologists.
Medical monitoring with baseline and follow-up trichoscopy tracks whether your hair is recovering (good — it’s pure TE) or whether follicle miniaturisation is progressing (not good — it’s FPHL and needs treatment).
What Won’t Address the Cause
Biotin supplements — unless a confirmed deficiency exists, which is rare. Worse, biotin interferes with thyroid and cardiac blood test results, potentially masking a thyroid problem that’s contributing to your hair loss.
“Hair growth” shampoos and scalp serums — no topical cosmetic product can reverse telogen effluvium or treat pattern hair loss. The cause is internal.
Stopping Wegovy without medical advice — you lose the metabolic and cardiovascular benefits, and if the underlying problem is unmasked FPHL rather than simple telogen effluvium, stopping won’t help your hair anyway. Always discuss medication changes with your prescribing doctor.
Wegovy Hair Loss Treatment at Hair GP
Our approach is built around one principle: diagnosis first, then treatment that actually matches what’s happening.
Doctor-led assessment. Our consultations are with a female hair loss doctor who can prescribe the full range of medical treatments — minoxidil, spironolactone, hormonal therapies — not just recommend products.
Comprehensive blood panel with hair-specific thresholds can be arranged privately if needed but many women bring in their NHS tests. For women on Wegovy, this consistently reveals iron deficiency, vitamin D insufficiency, and other gaps.
Trichoscopy — the critical step that distinguishes temporary shedding from progressive pattern hair loss. This is the information that determines whether your hair will recover on its own or needs medical intervention.
A plan that works alongside your medication. We’re not asking you to choose between your metabolic health and your hair. We diagnose what’s happening and treat the hair loss while you continue Wegovy.
What Patients Say
Frequently Asked Questions
Wegovy doesn’t directly damage hair follicles. The shedding occurs because rapid weight loss pushes follicles into their resting phase — a condition called telogen effluvium. In clinical trials, 3% of Wegovy participants reported hair loss compared to 1% on placebo. Women appear to be at higher risk than men.
For most women, it’s temporary — resolving within six to twelve months of weight stabilising. However, if the weight loss has unmasked underlying female pattern hair loss, that component won’t resolve without treatment. A diagnostic assessment can distinguish between the two.
Wegovy’s maintenance dose (2.4mg weekly) is higher than standard Ozempic doses, leading to greater appetite suppression and typically more rapid weight loss. More dramatic weight loss is a stronger trigger for telogen effluvium. For a full comparison of how GLP-1 medications affect hair, see our Ozempic hair loss guide.
Not without discussing it with your prescribing doctor. Wegovy provides significant metabolic and cardiovascular benefits — including NICE-approved use for reducing cardiovascular risk. Hair shedding can usually be managed alongside the medication through nutritional optimisation and medical treatment if needed.
A comprehensive panel should include ferritin (aim above 70 µg/L — not the standard GP threshold of 12), vitamin D, zinc, full blood count, thyroid function, and hormonal profile. Women on calorie-restricted diets are especially vulnerable to deficiencies that won’t show on standard GP blood work. Our blood test service uses hair-specific thresholds.
Yes — Mounjaro (tirzepatide) works through a similar mechanism and can trigger the same weight-loss-related shedding. Hair loss is listed as a common side effect of Mounjaro, reported in up to 5.7% of trial participants — higher than Wegovy’s 3%.Mounjaro Hair Loss
Book a Consultation
If you’re losing hair on Wegovy, the first step is understanding why — and whether it will resolve on its own or needs treatment.
Our comprehensive hair loss consultation gives you that clarity in a single appointment: blood panel with hair-specific thresholds, trichoscopy to distinguish temporary shedding from progressive hair loss, a clear diagnosis, and a treatment plan that works alongside your GLP-1 medication.
Book your consultation today — £300 including examination, trichoscopy, and treatment plan.
Understand what's causing your hair loss
A 50-minute consultation with Dr Amy includes scalp microscopy, and a personalised treatment plan—giving you definitive answers rather than continued guessing.
Book Your Hair Loss Assessment£300 consultation | Parsons Green, London
Next-day appointments often available
